Compare Amphastar Pharmaceuticals Inc (AMPH) vs Public Storage (PSA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Public Storage — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Public Storage trades at $320.06 (market cap $56.28B). The key difference: Public Storage is far larger — about 68.1× Amphastar Pharmaceuticals Inc's market cap, and Public Storage pays a 3.74% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | PSA | |
|---|---|---|
Market Cap | $826.08M | $56.28B |
Sector | Health | Real Estate |
52-Week High | $30.81 | $329.64 |
52-Week Low | $16.87 | $258.44 |
Enterprise Value | $1.22B | $70.53B |
Dividend Yield | — | 3.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Public Storage (PSA) trades at $320.56, up 0.38% with a bullish technical signal. The company demonstrates strong profitability with 39.16% net margins and consistent earnings beats. Recent developments include a $900 million note offering to fund the National Storage Affiliates acquisition and expansion into Canadian markets, signaling growth ambitions. Analyst consensus targets $332.25 with 65.72% hold ratings.
PSA offers stable income with recent dividend payments but faces execution risks from expansion initiatives. Valuation multiples appear elevated with P/E of 33.12, requiring sustained growth to justify premium pricing. The stock's near-term performance hinges on Q2 2026 earnings results due July 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
